Profitability
Weight: 25%
C-
47
- 5yr Avg ROIC 2.9%
- Operating Margin Trend +5.13 pp/yr
BMRN
BioMarin Pharmaceutical Inc.
AlphaQuality composite grade, weighted for platform & compounding fcf businesses.
Capital Efficiency
Weight: 15%
D-
29
- 5yr Avg ROE 3.4%
- 5yr Share-Count CAGR 1.9%
Growth Quality
Weight: 25%
A
92
- 5yr Revenue CAGR 14.9%
- 5yr EPS CAGR 33.9%
- Revenue-Growth Years (5) 4/5
Cash Generation
Weight: 20%
A-
84
- 5yr FCF Margin 10.9%
- 5yr FCF/NI Conversion 0.99x
Balance Sheet
Weight: 10%
A+
98
- Net Debt / EBITDA -1.60x
- Interest Coverage (EBIT/Int) 45.27x
- Altman Z-Score 3.75
Stability
Weight: 5%
D+
41
- EPS Volatility (σ/μ) 0.75
- Piotroski F-Score 5
- Negative-Revenue Years (5) 1/5
Guru Flow
Curated superinvestor sentiment — not part of the AlphaQuality grade.5 of 5 gurus held; 2 added; 3 trimmed.
- Holders
- 5
- Avg Δ position
- +53.0%
- New buys
- 0
- Full exits
- 0
- Cooperman increased +371%
- Wood decreased -77%
- Greenblatt decreased -35%